☆ 4.4 Article

Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2014)

Get Full Text
Add to Collection

Journal

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 37, Issue 10, Pages 1017-1030

Publisher

SPRINGER
DOI: 10.1007/s40618-014-0146-x

Keywords

Pegvisomant; Acromegaly; Somatostatin analogs; Growth hormone; IGF-1

Categories

Endocrinology & Metabolism

Funding

  1. Pfizer
  2. Ipsen
  3. Italfarmaco
  4. Novartis
  5. Viropharma
  6. IBSA

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.